Fri, Sep 19, 2014, 8:27 AM EDT - U.S. Markets open in 1 hr 3 mins


% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • moneyandstocks moneyandstocks May 9, 2013 1:27 PM Flag

    SRPT A Top Buy Among Funds . LINK

    Seeking Alpha By: Guru Fund Picks
    Sarepta Therapeutics (SRPT), that develops RNA-based therapeutics for the treatment of genetic, infectious and other diseases, in which mega funds together added a net 2.62 million shares in Q4 to their 2.89 million share prior quarter position in the company. In small-cap biotech stocks, SRPT was also a top buy among guru funds in Q4.

22.53-0.41(-1.79%)Sep 18 4:15 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.